Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies

Setenay Gupse Özcan, Clara Stanko, Lukasz Szymanski, Martin Fischer, Annamaria Brioli, Arthur Zelent, Tino Schenk

Open source

DOI
10.1038/s41416-026-03512-z
Published
2026-07-02
Container
British Journal of Cancer
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41416-026-03512-z,
  title = {Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies},
  author = {Setenay Gupse Özcan and Clara Stanko and Lukasz Szymanski and Martin Fischer and Annamaria Brioli and Arthur Zelent and Tino Schenk},
  year = {2026},
  journal = {British Journal of Cancer},
  doi = {10.1038/s41416-026-03512-z},
  url = {https://doi.org/10.1038/s41416-026-03512-z}
}

RIS

TY  - JOUR
TI  - Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies
AU  - Setenay Gupse Özcan
AU  - Clara Stanko
AU  - Lukasz Szymanski
AU  - Martin Fischer
AU  - Annamaria Brioli
AU  - Arthur Zelent
AU  - Tino Schenk
PY  - 2026
JO  - British Journal of Cancer
DO  - 10.1038/s41416-026-03512-z
UR  - https://doi.org/10.1038/s41416-026-03512-z
ER  - 

APA

Özcan, S. G., Stanko, C., Szymanski, L., Fischer, M., Brioli, A., Zelent, A., & Schenk, T. (2026). Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03512-z

Source records